These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 32411671)

  • 1. Structure-Based Virtual Screening: From Classical to Artificial Intelligence.
    Maia EHB; Assis LC; de Oliveira TA; da Silva AM; Taranto AG
    Front Chem; 2020; 8():343. PubMed ID: 32411671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting machine-learning scoring functions for structure-based virtual screening.
    Ballester PJ
    Drug Discov Today Technol; 2019 Dec; 32-33():81-87. PubMed ID: 33386098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review.
    Sabe VT; Ntombela T; Jhamba LA; Maguire GEM; Govender T; Naicker T; Kruger HG
    Eur J Med Chem; 2021 Nov; 224():113705. PubMed ID: 34303871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational methods in drug discovery.
    Leelananda SP; Lindert S
    Beilstein J Org Chem; 2016; 12():2694-2718. PubMed ID: 28144341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into Machine Learning-based Approaches for Virtual Screening in Drug Discovery: Existing Strategies and Streamlining Through FP-CADD.
    Hussain W; Rasool N; Khan YD
    Curr Drug Discov Technol; 2021; 18(4):463-472. PubMed ID: 32767944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD).
    Lee JW; Maria-Solano MA; Vu TNL; Yoon S; Choi S
    Biochem Soc Trans; 2022 Feb; 50(1):241-252. PubMed ID: 35076690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical guide to machine-learning scoring for structure-based virtual screening.
    Tran-Nguyen VK; Junaid M; Simeon S; Ballester PJ
    Nat Protoc; 2023 Nov; 18(11):3460-3511. PubMed ID: 37845361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine.
    Lin Y; Zhang Y; Wang D; Yang B; Shen YQ
    Phytomedicine; 2022 Dec; 107():154481. PubMed ID: 36215788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role and potential of computer-aided drug discovery strategies in the discovery of novel antimicrobials.
    Oselusi SO; Dube P; Odugbemi AI; Akinyede KA; Ilori TL; Egieyeh E; Sibuyi NR; Meyer M; Madiehe AM; Wyckoff GJ; Egieyeh SA
    Comput Biol Med; 2024 Feb; 169():107927. PubMed ID: 38184864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VSDMIP 1.5: an automated structure- and ligand-based virtual screening platform with a PyMOL graphical user interface.
    Cabrera ÁC; Gil-Redondo R; Perona A; Gago F; Morreale A
    J Comput Aided Mol Des; 2011 Sep; 25(9):813-24. PubMed ID: 21826555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free resources to assist structure-based virtual ligand screening experiments.
    Villoutreix BO; Renault N; Lagorce D; Sperandio O; Montes M; Miteva MA
    Curr Protein Pept Sci; 2007 Aug; 8(4):381-411. PubMed ID: 17696871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-based virtual screening protocol for drug discovery.
    Cerqueira NM; Gesto D; Oliveira EF; Santos-Martins D; Brás NF; Sousa SF; Fernandes PA; Ramos MJ
    Arch Biochem Biophys; 2015 Sep; 582():56-67. PubMed ID: 26045247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based virtual screening for drug discovery: a problem-centric review.
    Cheng T; Li Q; Zhou Z; Wang Y; Bryant SH
    AAPS J; 2012 Mar; 14(1):133-41. PubMed ID: 22281989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus scoring criteria for improving enrichment in virtual screening.
    Yang JM; Chen YF; Shen TW; Kristal BS; Hsu DF
    J Chem Inf Model; 2005; 45(4):1134-46. PubMed ID: 16045308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PL-PatchSurfer3: Improved Structure-Based Virtual Screening for Structure Variation Using 3D Zernike Descriptors.
    Shin WH; Kihara D
    bioRxiv; 2024 Feb; ():. PubMed ID: 38464318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based virtual screening for drug discovery: principles, applications and recent advances.
    Lionta E; Spyrou G; Vassilatis DK; Cournia Z
    Curr Top Med Chem; 2014; 14(16):1923-38. PubMed ID: 25262799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift.
    Usha T; Shanmugarajan D; Goyal AK; Kumar CS; Middha SK
    Curr Top Med Chem; 2017; 17(30):3296-3307. PubMed ID: 29295698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations in compound database preparation--"hidden" impact on virtual screening results.
    Knox AJ; Meegan MJ; Carta G; Lloyd DG
    J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Hybrid Virtual Screening Protocol Based on Binding Mode Similarity.
    Anighoro A; Bajorath J
    Methods Mol Biol; 2018; 1824():165-175. PubMed ID: 30039406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined strategies in structure-based virtual screening.
    Wang Z; Sun H; Shen C; Hu X; Gao J; Li D; Cao D; Hou T
    Phys Chem Chem Phys; 2020 Feb; 22(6):3149-3159. PubMed ID: 31995074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.